This searchable database contains all of DIRC’s current published documents. Access is restricted to members only. Pay-per-view options are available if you are not a member but wish to purchase a single document.

We serve both large and small clients and take pride in our responsiveness to your needs.

Sign-Up for off-line printed publications


    posted from


    TitleDescriptionPosting DateResource TypePay-per-view access
     eDIRC Bulletin Vol. 4 (8)Health Canada advisories regarding reports of infliximab and hepatosplenic T-cell lymphoma in pediatric and young adult patients, and increase in the rate of non-syndromic oral clefts and use of lamotrigine in pregnancy ; the Canadian Psychiatric Association`s 2006 guidelines for the management of anxiety disorders ; online links to issues of Hospital Pharmacist, American Family Physician, CFP, CMAJ, and BMJ.Aug. 28, 2006Email Bulletins$0.00
     eDIRC Bulletin Vol. 4 (7)Health Canada advisories regarding reports of tipranavir and intracranial hemorrhage, reports of erectile dysfunction medications and visual disturbances, and a recent study published in NEJM on use of ACEI`s during pregnancy ; Canadian Adverse Reaction Newsletter on the rationale and importance for reporting ADR`s in children ; online links to Bandolier, Institute for Safe Medication Practices Canada (ISMP) bulletins, issues of Hospital Pharmacist, Canadian Family Physician (CFP), Aerican Family Physician (AFP), and CMAJ.Aug. 21, 2006Email Bulletins$0.00
     Therapeutic Options : Focus on Atrial FibrillationClassification, pathophysiology and risk factors, management approach, drugs used for rhythm control, rate control, prevention of thromboembolism, antithrombotic therapy algorithm for patients with atrial fibrillation.July 26, 2006Therapeutic Options$5.30
     New Drugs/Drug News Jul/Aug 2006Medications in the Pipeline – Duloxetine (Cymbalta), entecavir (Baraclude), Anya, Seasonale, exenatide (Byetta), inhaled insulin (Exubera), r-flurbiprofen (Flurizan), rimonabant (Acomplia), varenicline (Chantix).July 26, 2006New Drugs/Drug News$5.30
     DIRC Update : West Nile Virus 2006Transmission, symptoms, treatment and prevention, including list of registered insect repellents in Canada and insect repellent counselling tips.June 20, 2006Public Resources$0.00
     eDIRC Bulletin Vol. 4 (5)University of Arizona Center for Education and Research on Therapeutics` list of drugs that can potentially prolong the QT interval ; Health Canada Advisory on raloxifene and increase in the incidence of deaths due to stroke in individuals at risk of cardiovacular disease ; CADTH`s information regarding use of the investigational vaccine Zostavax for the prevention of shingles and postherpetic neuralgia ; the Public Health Agency of Canada`s guidelines for the prevention and treatment of sexually transmitted infections, and updated recommendations for the routine use of Pneumococcal conjugate vaccine for infants.June 16, 2006Email Bulletins$0.00
     eDIRC Bulletin Vol. 4 (4)Canadian Adverse Reaction Newsletter on reports of acute renal failure & tenofovir, and on reports of vascular disorders & MI with use of isotretinoin; Health Canada Advisory on gatifloxacin contraindication in patients with diabetes; OCP update on the rescheduling of pseudoephedrine and ephedrine; American Association of Endodontist`s position statement regarding bisphosphonate-induced osteonecrosis of the jaw; National OB/GYN Society`s new recommendation regarding Depo-Provera and link to loss of bone density.May 26, 2006New Drugs/Drug News$5.30
     New Drugs/Drug News May/Jun 2006Insulin Therapy – Frequently Asked Questions.May 25, 2006New Drugs/Drug News$5.30
     eDIRC Bulletin Vol. 4 (3)Canadian Adverse Reaction Newsletter on tenofovir & reports of acute renal failure, and isotretinoin & reports of vascular disorders and MI ; OCP update on the rescheduling of pseudoephedrine and ephedrine.Apr. 28, 2006Email Bulletins$0.00
     New Drugs/Drug News Mar/Apr 2006Epinephrine Injection (Twinject) : Background, approved indications, pharmacology, efficacy, adverse reactions and precautions, drug interactions, dosage and administration, availability and cost, place in therapy.Mar. 20, 2006New Drugs/Drug News$5.30
     eDIRC Bulletin Vol. 4 (2)Canadian Adverse Reaction Newsletter reports on concurrent use of warfarin & oseltamivir and increase in INR, and use of rosiglitazone & parotid gland enlargenment ; Health Canada advisories regarding WinRho SDF & intravascular hemolysis, and telithromycin & liver failure ; NEJM articles on gatifloxacin & potentially serious glycemic reactions, and calcium plus vitamin D & risk of hip fracture ; CDC guidelines for influenza vaccination of health-care personnel ; links to Australian Prescriber and WHO Pharmaceuticals Newsletter.Mar. 6, 2006Email Bulletins$0.00
     eDIRC Bulletin Vol. 4 (1)DIRC articles on Pharmacotherapy for Carpal Tunnel Syndrome and Lateral Epicondylitis, and Bipolar Disorder in Women ; Health Canada Warnings and Advisories ; American College of Chest Physicians` guidelines on treatment of acute cough and upper airway cough syndrome ; approval of Exubera inhaled insulin in the United States.Feb. 15, 2006Email Bulletins$0.00
     Therapeutic Options : Focus on Bipolar Disorder in WomenGeneral considerations, pregnancy and treatment considerations, breastfeeding and treatment considerations, FAQs.Feb. 13, 2006Therapeutic Options$5.30
     New Drugs/Drug News Jan/Feb 2006Docosanol 10% Cream (Abreva) : Background, approved indications, pharmacology, evidence of efficacy, adverse reactions and precautions, drug interactions, dosage and duration, cost comparison, counseling tips, place in therapy, conclusion, references. Cumulative index 2000 to 2005.Feb. 13, 2006New Drugs/Drug News$5.30
     WSIB : Drug News Update, Winter 2005Pregabalin (Lyrica) : Pharmacology, efficacy, adverse effects and precautions, drug interactions, dosage and administration, place in therapy.Feb. 13, 2006WSIB Newsletter$5.30
     WSIB : Drug News Update, Fall 2005Pharmacotherapy for Carpal Tunnel Syndrome and Lateral Epicondylitis : Corticosteroids, other medications, non-pharmacological therapy.Feb. 13, 2006WSIB Newsletter$5.30
     eDIRC Bulletin Vol. 3 (13)DIRC overview on pregabalin (Lyrica) ; Therapeutic Options articles on influenza & influenza vaccination, and benign prostatic hyperplasia ; Health Cdanada Advisories include contraindication of letrozole (Femara) in premenopausal women, as well as during pregnancy/lactation ; OPA information on changes to the drug benefits administered by Green Shield.Dec. 16, 2005Email Bulletins$0.00
     Therapeutic Options : Focus on Benign Prostatic HyperplasiaFocus on Benign Prostatic Hyperplasia – Definition, diagnosis, treatment strategies, special situations, useful websites.Dec. 15, 2005Therapeutic Options$5.30
     New Drugs/Drug News Nov/Dec 2005Pregabalin (Lyrica) : Backgound information, approved indications, pharmacology, pharmacokinetics, efficacy, summary of pregabalin trials, adverse events and precautions, drug interactions, dosage and administration, place in therapy, availability and cost.Dec. 7, 2005New Drugs/Drug News$5.30
     eDIRC Bulletin Vol. 3 (12)Avian influenza FAQs ; Health Canada advisories on atomoxetine & increased risk of self harm, and paroxetine & increased risk of congenital malformations in the first trimester of pregnancy ; AstraZeneca announcement of the discontinuation of quetiapine ; Australian Prescriber`s article on the use of pychotropic medications in children ; BMJ`s perspective regarding the risks of the avian flu.Nov. 8, 2005Email Bulletins$0.00